Nabla Bio, Inc.
Nabla Bio is a biotechnology company that uses artificial intelligence to design antibodies for intractable diseases, aiming to transform drug development into a design discipline by reducing trial-and-error processes.
About Nabla Bio, Inc.
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
Products
An integrated engine combining generative AI (JAM) with large-scale, human-relevant testing to design antibodies and biologics, enabling de novo design, epitope scaffolding, and...
Security and compliance
No security details published yet
Nabla Bio, Inc. hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Nabla Bio, Inc.